Charles River Laboratories International CRL
NYSE CRL
$322.43 -3.86 (-1.18%)
As of: Nov 5, 2026 · 12:22 PM EST

Charles River Laboratories International (CRL) Current Deferred Tax Liability (2010 - 2011)

Updated

Analysis

Charles River Laboratories International (CRL) Current Deferred Tax Liability (2010 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.45 Bn 34.71 Bn 1.50 Bn
2 Medpace Holdings 18.14 Bn 15.78 Bn 223.89 Mn
3 Icon 15.66 Bn 12.43 Bn 491.83 Mn
4 Charles River Laboratories International 15.44 Bn 14.64 Bn 363.37 Mn
5 Fortrea Holdings 1.97 Bn 1.25 Bn 139.50 Mn
6 Ginkgo Bioworks Holdings 633.05 Mn -129.03 Mn 18.44 Mn
7 Evotec SE 587.78 Mn -1.02 Bn -
8 Champions Oncology 67.40 Mn 42.49 Mn 7.70 Mn
9 MindWalk Holdings 48.24 Mn 11.89 Mn 1.61 Mn
10 Natural Alternatives International 6.63 Mn -21.45 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 24, 2011 1.07 Mn
Jun 25, 2011 1.12 Mn
Dec 25, 2010 963,000.00
API Access

Charles River Laboratories International Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=CRL&period=max&api_key=YOUR_API_KEY